Adverse Pregnancy OutcomesNCT04215406
The Mechanism of Adverse Pregnancy Outcomes Influenced by Maternal Air Pollution Exposure
An observational study of Adverse Pregnancy Outcomes, run by First Affiliated Hospital Xi'an Jiaotong University at 1 site in China.
Trial summary
This research evaluates the effects of maternal exposure to air pollution during pregnancy on adverse pregnancy outcomes, the general demographic information, the level of maternal exposure to air pollution, pregnancy-related information, the occurrence of adverse pregnancy outcomes, and serum indicators of pregnant… Read more about this study
- Who is it for?
- Ages 20 to 40 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Adverse Pregnancy Outcomes
- What is being tested?
- The level of air pollution
- How many people
- 288 participants
- Where
- 1 siteChina
- Study dates
- 1 Jan 2020to 30 Jun 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: The study participants are healthy pregnant women within 6 weeks of pregnancy from the First Affiliated Hospital of Xi'an Jiaotong University, who meet the inclusion and exclusion criteria, and sign the informed consent before the implementation of this research. All the participants will be followed up about 9 months and measured the serum concentration of inflammatory cytokine and hormone.
Who may be able to join
- The Pregnant women within 6 weeks of gestation from the First Affiliated Hospital of Xi'an Jiaotong University;
- This pregnancy is natural conception, the last menstrual period is definite and the menstrual cycle is basically regular;
- The pregnant examinations are performed in our hospital;
- The pregnant women volunteer to participate in this study and sign the informed consent.
Who cannot join
- The couples have chromosomal abnormalities or hereditary diseases;
- The pregnant women have trophoblastic diseases such as hydatidiform mole;
- The pregnant women with genital malformations, such as mediastinal uterus, single-horned uterus, double uterus, etc;
- The pregnant women are definitively diagnosed with uterine fibroids, ovarian cysts, polycystic ovary syndrome, gynecological inflammation and other gynecological diseases;
- The pregnant women are definitively diagnosed with hypertensive, diabetes and other chronic disease before pregnancy;
- The pregnant women are definitively diagnosed with autoimmune diseases such as systemic lupus erythematosus, multiple arteriolar inflammation, rheumatoid arthritis, etc;
- The participants have other serious diseases.
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710000
Wenfang Yang, PHD, 0086-029-85323223, wenfang.yang@xjtu.edu.cn
Boxing Zhang, 0086-15029530460, 502209064@qq.com
About this study
Official title: The Effects of Maternal Exposure to Air Pollution During Pregnancy on Adverse Pregnancy Outcomes Mediated by Inflammatory Cytokine and Hormone
This research evaluates the effects of maternal exposure to air pollution during pregnancy on adverse pregnancy outcomes, the general demographic information, the level of maternal exposure to air pollution, pregnancy-related information, the occurrence of adverse pregnancy outcomes, and serum indicators of pregnant women during pregnancy are collected. Finally, the research explores that whether the inflammatory cytokine and hormone can mediate the occurrence of adverse pregnancy outcomes under the maternal exposure to air pollution during pregnancy.
Read the detailed description
Pregnancy is the most important period in the life process. China have a high occurrence of adverse pregnancy outcomes and the situation of air pollution is not optimistic. With the introduction of perspective in environment and health, the impact of air pollution on health has received extensive attention. A large number of studies have confirmed that maternal exposure to air pollution during pregnancy such as particulate matter (PM), nitrogen dioxide (NO2), sulfur dioxide (SO2), ozone (O3), carbon monoxide (CO) can increase the risk of miscarriage, gestational diabetes mellitus(GDM), hypertensive disorder complicating pregnancy, preterm birth and low birth weight(LBW). Maternal exposure to air pollution was also closely related to birth defects, newborn congenital hypothyroidism, and affect neurodevelopment in offspring. In other respects, studies shown that air pollution can change maternal steroid hormone levels (human chorionic gonadotropin (hCG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol(E2) and progesterone(P)), which play an important role in maintaining pregnancy and the developing of adverse pregnancy outcomes. Interleukin (IL) is an important inflammatory mediator cytokine, IL-8, IL-6 and IL-2 are closely related to the reproductive process of mammals and may regulate the occurrence of adverse pregnancy outcomes and influenced by air pollution, but limited studies focused on them in regulating the occurrence of adverse pregnancy outcomes under exposure to air pollution. So, a prospective cohort study is conducted to explore the new mechanism of adverse pregnancy outcomes affected by air pollution.
Research content: This research is a prospective cohort study from January 2020 to December 2022, 288 pregnant women will be recruited from the First Affiliated Hospital of Xi'an Jiaotong University. A health management birth cohort will be established. The subjects will be enrolled within 6 weeks of gestation, and be followed up about 9 months: ①To construct a spatial and temporal series about adverse pregnancy outcomes influenced by maternal exposure to air pollution during pregnancy; ②To explore the effects of maternal exposure to air pollution on hormone and inflammatory cytokine during pregnancy, and the relationship between maternal level of hormone, inflammation cytokine and adverse pregnancy outcomes; ③To determine if maternal hormone and inflammatory cytokine mediate the occurrence of adverse pregnancy outcomes during pregnancy under maternal exposure to air pollution as intermediate regulatory product.
Research meaning:①To explore the mechanism of adverse pregnancy outcomes affected by air pollution during pregnancy, provide an epidemic evidence for interposing the occurrence of adverse pregnancy outcomes by regulating maternal hormone and inflammatory cytokine; ②To define the critical period of the developing of adverse pregnancy outcomes in spatial and temporal series, and to calculate the cutoff value of air pollution on adverse pregnancy outcomes, propose short-term control target of air pollution related to maternal and child health, construct the first-level prevention strategy for adverse pregnancy outcomes.
Research steps: ① Complete the recruiting of subjects, which meet the inclusion and exclusion criteria sign an informed consent before the carrying out of research; ② Follow up: Three questionnaires will be conducted at the end of each trimester to acquire the information including sociodemographic characteristics, menstrual history and childbearing history, residence during pregnancy, lifestyle and diet habits, the information of illness and medication, history of past illness, etc. Then the maternal exposure level of air pollutants in every trimester will be calculated, based on air pollution detection station, from Shaanxi Meteorological and Environment Bureau according to residence information of participants; ③ Serum indicators: fasting venous blood samples will be taken at different time points to detect serum level of maternal hormone and inflammatory cytokine, all the venous blood samples will be taken and tested in the laboratory of First Affiliated Hospital of Xi'an Jiaotong University. 4 mL of fasting venous blood sample are needed, and the blood sample will be put in dry test tubes, centrifuged within 1 hour, and the separated serum was stored at -20 ° C, chemiluminescence and ELASA will be adapted to detect the samples respectively. ④ Monitoring of adverse pregnancy outcomes: closely monitor the occurrence of adverse pregnancy outcomes during pregnancy. During the whole study period, the subjects could withdraw the cohort at any time.
Abortion: The abortion includes early spontaneous abortion (occur within 12 weeks of gestation), late spontaneous abortion (occur from 12 weeks to 28 weeks of gestation) and missed abortion included(embryo die in the uterine cavity and fail to excrete themselves at time); Maternal adverse pregnancy outcomes: hypertension disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, chronic hypertension), GDM (referring to diabetes occur in pregnancy and the glucose metabolism is normal before pregnancy). Adverse outcomes for fetus or newborn: including preterm birth (delivery form 28 weeks to 37 weeks of gestation); low birth weight (newborn weight measured within 72 hours after birth is less than 2500 grams); birth defects (fetal structural, functional or metabolic abnormalities, also known as congenital malformations).
Statistical method: ①Univariate analysis: The maternal exposure levels of air pollution during pregnancy will be treated as independent variables, pregnancy outcomes will be treated as dependent variables, univariate logistic regression will be used to analyze the relationship between them; Then, maternal exposure levels will be treated as independent variables, maternal hormone and inflammatory cytokine as the dependent variable, the univariate logistic regression analysis will be used to analyze the relationship between them; Finally, the level of hormone and inflammatory cytokine will be treated as independent variables, pregnancy outcomes as dependent variables, and analyze the relationship between them; ②Multivariate analysis: adverse pregnancy outcomes will be taken as dependent variables, maternal exposure levels, sociodemographic characteristics, nutritional status, dietary status, and other factors are included as independent variables, the multivariate logistic regression analysis will be used to data analysis. In the multivariate regression the odds ration value and 95% confidence intervention of air pollution to affect adverse pregnancy outcomes will be calculated adjusted for sociodemographic characteristics, nutrition, dietary conditions and other factors; ③Analysis of intermediary factor: mediate effect analysis will be used to analyze whether the maternal hormone and inflammatory cytokine mediate the occurrence of adverse pregnancy outcomes as intermediate regulatory products under maternal air pollution exposure; ④ Spatial and temporal series analysis will be adapted to define the critical period of the developing of adverse pregnancy outcomes under maternal exposure to air pollution, and calculate the cut-off value of air pollution about the adverse pregnancy outcomes.
Research planning: ①Complete research design, follow-up questionnaires, and pre-experiments before 2020; ②Complete enrollment of subjects, follow-up of the study subjects, detecting of serum indicators, monitor the occurrence of adverse pregnancy outcomes before January 2021; ③Complete data export and analysis about basic information and data analysis; ④Clarify the relationship between maternal air pollution exposure during pregnancy and adverse pregnancy outcomes, explore the potential mechanism in the occurrence of adverse pregnancy outcomes influenced by air pollution.
- Conditions
- Adverse Pregnancy Outcomes
- Being tested
- The level of air pollution
- Keywords
- pregnancy, air pollution, inflammatory cytokine, hormone, effect
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
The level of air pollutionOther
The intervention measure is the level of air pollution, it is a non-human interventional measure based on the weighted average of various air pollutants monitored by air pollution monitoring stations during different period of pregnancy.
| Study group | Role | What they receive |
|---|---|---|
| The level of maternal air pollution exposure during pregnancy | The groups will be decided according to the level of maternal exposure to air pollution during pregnancy. Participants will be divided into experimental group (high level of maternal air pollution exposure) and control group (low level of maternal air pollution exposure) or other groups according to research and actual demand. Receives: Other: The level of air pollution |
What is being measured
The primary outcome is the main question the study is designed to answer.
The occurrence of adverse pregnancy outcomes or delivery
Adverse pregnancy outcomes including abortion, gestational diabetes mellitus (GDM), hypertensive disorder complicating pregnancy, preterm birth, birth defects and low birth weight(LBW).
Measured: ①For abortion, up to 24 weeks. ②For participants without abortion will be assessed when hypertension disorders of pregnancy and GDM occur, then assessment of preterm birth, LBW and birth defects will be conducted when delivery, up to about 9 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jan 2020
- Study start1 Jan 2020
- Primary completion30 Jun 2023 (estimated)
- Study completion30 Jun 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Adverse Pregnancy OutcomesStudies of the same condition, open and under way.
- More trials run by First Affiliated Hospital Xi'an Jiaotong UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 288 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Wenfang Yang, PHD, Study director, First Affiliated Hospital Xi'an Jiaotong University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04215406
- Sponsor's protocol ID
- XJTU1AF-CRF-2019-023
- Status last verified
- Aug 2021
- First submitted
- 25 Dec 2019
- Last updated
- 29 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Maternal Exposure to Air Pollution During Pregnancy on Adverse Pregnancy Outcomes Mediated by Inflammatory Cytokine and Hormone
- ClinicalTrials.gov ID
- NCT04215406
- Acronym / sponsor ID
- XJTU1AF-CRF-2019-023
- Conditions
- Adverse Pregnancy Outcomes
- Keywords
- pregnancy, air pollution, inflammatory cytokine, hormone, effect
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 288 participants (estimated)
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong UniversityUniversity, hospital or other
- Study start
- 1 Jan 2020 (actual)
- Primary completion
- 30 Jun 2023 (estimated)
- Study completion
- 30 Jun 2023 (estimated)
- First posted
- 2 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research evaluates the effects of maternal exposure to air pollution during pregnancy on adverse pregnancy outcomes, the general demographic information, the level of maternal exposure to air pollution, pregnancy-related information, the occurrence of adverse pregnancy outcomes, and serum indicators of pregnant women during pregnancy are collected. Finally, the research explores that whether the inflammatory cytokine and hormone can mediate the occurrence of adverse pregnancy outcomes under the maternal exposure to air pollution during pregnancy.
Detailed description
Pregnancy is the most important period in the life process. China have a high occurrence of adverse pregnancy outcomes and the situation of air pollution is not optimistic. With the introduction of perspective in environment and health, the impact of air pollution on health has received extensive attention. A large number of studies have confirmed that maternal exposure to air pollution during pregnancy such as particulate matter (PM), nitrogen dioxide (NO2), sulfur dioxide (SO2), ozone (O3), carbon monoxide (CO) can increase the risk of miscarriage, gestational diabetes mellitus(GDM), hypertensive disorder complicating pregnancy, preterm birth and low birth weight(LBW). Maternal exposure to air pollution was also closely related to birth defects, newborn congenital hypothyroidism, and affect neurodevelopment in offspring. In other respects, studies shown that air pollution can change maternal steroid hormone levels (human chorionic gonadotropin (hCG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol(E2) and progesterone(P)), which play an important role in maintaining pregnancy and the developing of adverse pregnancy outcomes. Interleukin (IL) is an important inflammatory mediator cytokine, IL-8, IL-6 and IL-2 are closely related to the reproductive process of mammals and may regulate the occurrence of adverse pregnancy outcomes and influenced by air pollution, but limited studies focused on them in regulating the occurrence of adverse pregnancy outcomes under exposure to air pollution. So, a prospective cohort study is conducted to explore the new mechanism of adverse pregnancy outcomes affected by air pollution.
Research content: This research is a prospective cohort study from January 2020 to December 2022, 288 pregnant women will be recruited from the First Affiliated Hospital of Xi'an Jiaotong University. A health management birth cohort will be established. The subjects will be enrolled within 6 weeks of gestation, and be followed up about 9 months: ①To construct a spatial and temporal series about adverse pregnancy outcomes influenced by maternal exposure to air pollution during pregnancy; ②To explore the effects of maternal exposure to air pollution on hormone and inflammatory cytokine during pregnancy, and the relationship between maternal level of hormone, inflammation cytokine and adverse pregnancy outcomes; ③To determine if maternal hormone and inflammatory cytokine mediate the occurrence of adverse pregnancy outcomes during pregnancy under maternal exposure to air pollution as intermediate regulatory product.
Research meaning:①To explore the mechanism of adverse pregnancy outcomes affected by air pollution during pregnancy, provide an epidemic evidence for interposing the occurrence of adverse pregnancy outcomes by regulating maternal hormone and inflammatory cytokine; ②To define the critical period of the developing of adverse pregnancy outcomes in spatial and temporal series, and to calculate the cutoff value of air pollution on adverse pregnancy outcomes, propose short-term control target of air pollution related to maternal and child health, construct the first-level prevention strategy for adverse pregnancy outcomes.
Research steps: ① Complete the recruiting of subjects, which meet the inclusion and exclusion criteria sign an informed consent before the carrying out of research; ② Follow up: Three questionnaires will be conducted at the end of each trimester to acquire the information including sociodemographic characteristics, menstrual history and childbearing history, residence during pregnancy, lifestyle and diet habits, the information of illness and medication, history of past illness, etc. Then the maternal exposure level of air pollutants in every trimester will be calculated, based on air pollution detection station, from Shaanxi Meteorological and Environment Bureau according to residence information of participants; ③ Serum indicators: fasting venous blood samples will be taken at different time points to detect serum level of maternal hormone and inflammatory cytokine, all the venous blood samples will be taken and tested in the laboratory of First Affiliated Hospital of Xi'an Jiaotong University. 4 mL of fasting venous blood sample are needed, and the blood sample will be put in dry test tubes, centrifuged within 1 hour, and the separated serum was stored at -20 ° C, chemiluminescence and ELASA will be adapted to detect the samples respectively. ④ Monitoring of adverse pregnancy outcomes: closely monitor the occurrence of adverse pregnancy outcomes during pregnancy. During the whole study period, the subjects could withdraw the cohort at any time.
Abortion: The abortion includes early spontaneous abortion (occur within 12 weeks of gestation), late spontaneous abortion (occur from 12 weeks to 28 weeks of gestation) and missed abortion included(embryo die in the uterine cavity and fail to excrete themselves at time); Maternal adverse pregnancy outcomes: hypertension disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, chronic hypertension), GDM (referring to diabetes occur in pregnancy and the glucose metabolism is normal before pregnancy). Adverse outcomes for fetus or newborn: including preterm birth (delivery form 28 weeks to 37 weeks of gestation); low birth weight (newborn weight measured within 72 hours after birth is less than 2500 grams); birth defects (fetal structural, functional or metabolic abnormalities, also known as congenital malformations).
Statistical method: ①Univariate analysis: The maternal exposure levels of air pollution during pregnancy will be treated as independent variables, pregnancy outcomes will be treated as dependent variables, univariate logistic regression will be used to analyze the relationship between them; Then, maternal exposure levels will be treated as independent variables, maternal hormone and inflammatory cytokine as the dependent variable, the univariate logistic regression analysis will be used to analyze the relationship between them; Finally, the level of hormone and inflammatory cytokine will be treated as independent variables, pregnancy outcomes as dependent variables, and analyze the relationship between them; ②Multivariate analysis: adverse pregnancy outcomes will be taken as dependent variables, maternal exposure levels, sociodemographic characteristics, nutritional status, dietary status, and other factors are included as independent variables, the multivariate logistic regression analysis will be used to data analysis. In the multivariate regression the odds ration value and 95% confidence intervention of air pollution to affect adverse pregnancy outcomes will be calculated adjusted for sociodemographic characteristics, nutrition, dietary conditions and other factors; ③Analysis of intermediary factor: mediate effect analysis will be used to analyze whether the maternal hormone and inflammatory cytokine mediate the occurrence of adverse pregnancy outcomes as intermediate regulatory products under maternal air pollution exposure; ④ Spatial and temporal series analysis will be adapted to define the critical period of the developing of adverse pregnancy outcomes under maternal exposure to air pollution, and calculate the cut-off value of air pollution about the adverse pregnancy outcomes.
Research planning: ①Complete research design, follow-up questionnaires, and pre-experiments before 2020; ②Complete enrollment of subjects, follow-up of the study subjects, detecting of serum indicators, monitor the occurrence of adverse pregnancy outcomes before January 2021; ③Complete data export and analysis about basic information and data analysis; ④Clarify the relationship between maternal air pollution exposure during pregnancy and adverse pregnancy outcomes, explore the potential mechanism in the occurrence of adverse pregnancy outcomes influenced by air pollution.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| The level of maternal air pollution exposure during pregnancy | – | Other: The level of air pollutionThe groups will be decided according to the level of maternal exposure to air pollution during pregnancy. Participants will be divided into experimental group (high level of maternal air pollution exposure) and control group (low level of maternal air pollution exposure) or other groups according to research and actual demand. |
Who may qualify
- Ages
- 20 to 40 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- The study participants are healthy pregnant women within 6 weeks of pregnancy from the First Affiliated Hospital of Xi'an Jiaotong University, who meet the inclusion and exclusion criteria, and sign the informed consent before the implementation of this research. All the participants will be followed up about 9 months and measured the serum concentration of inflammatory cytokine and hormone.
Key inclusion criteria (4 listed)
- The Pregnant women within 6 weeks of gestation from the First Affiliated Hospital of Xi'an Jiaotong University;
- This pregnancy is natural conception, the last menstrual period is definite and the menstrual cycle is basically regular;
- The pregnant examinations are performed in our hospital;
- The pregnant women volunteer to participate in this study and sign the informed consent.
Key exclusion criteria (7 listed)
- The couples have chromosomal abnormalities or hereditary diseases;
- The pregnant women have trophoblastic diseases such as hydatidiform mole;
- The pregnant women with genital malformations, such as mediastinal uterus, single-horned uterus, double uterus, etc;
- The pregnant women are definitively diagnosed with uterine fibroids, ovarian cysts, polycystic ovary syndrome, gynecological inflammation and other gynecological diseases;
- The pregnant women are definitively diagnosed with hypertensive, diabetes and other chronic disease before pregnancy;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| The level of air pollutionThe intervention measure is the level of air pollution, it is a non-human interventional measure based on the weighted average of various air pollutants monitored by air pollution monitoring stations during different period of pregnancy. | Other | The level of maternal air pollution exposure during pregnancy |
Primary outcome
The occurrence of adverse pregnancy outcomes or delivery
Time frame: ①For abortion, up to 24 weeks. ②For participants without abortion will be assessed when hypertension disorders of pregnancy and GDM occur, then assessment of preterm birth, LBW and birth defects will be conducted when delivery, up to about 9 months
Adverse pregnancy outcomes including abortion, gestational diabetes mellitus (GDM), hypertensive disorder complicating pregnancy, preterm birth, birth defects and low birth weight(LBW).
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2022.
- Individual participant dataSharing planned: No
Related trials for Adverse Pregnancy Outcomes
RecruitingPhase 3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease
Not yet recruiting
A Study to Lower Blood Pressure One Year After Childbirth in Women Who Had Preeclampsia
Adverse Pregnancy Outcomes, Cardiovascular Diseases
Active, not recruiting
Providing an Optimized and Empowered Pregnancy for You (POPPY) Aim 3: Randomized Controlled Trial
Pregnancy Complications, Maternal Distress
Recruiting
The Ophthalmic Artery Doppler Evaluation Prior to Labor Induction and Adverse Intrapartum Fetal Outcomes
Ophthalmic Artery, Labor and Delivery
Not yet recruitingObservational study
Malnutrition and Sarcopenia in Adults With Chronic Kidney Disease in Tunisia
Malnutrition, Sarcopenia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Wenfang Yang, PHD study director
First Affiliated Hospital Xi'an Jiaotong University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Adverse Pregnancy Outcomes, run by First Affiliated Hospital Xi'an Jiaotong University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Wenfang Yang, PHD (0086-029-85323223, wenfang.yang@xjtu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The occurrence of adverse pregnancy outcomes or delivery (time frame: ①For abortion, up to 24 weeks. ②For participants without abortion will be assessed when hypertension disorders of pregnancy and GDM occur, then assessment of preterm birth, LBW and birth defects will be conducted when delivery, up to about 9 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2022.